No association of polymorphisms of the CTLA-4 exon 1(+49) and promoter(-318) genes with rheumatoid arthritis in the Korean population

被引:26
作者
Lee, YH [1 ]
Choi, SJ [1 ]
Ji, JD [1 ]
Song, GG [1 ]
机构
[1] Korea Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul 136701, South Korea
关键词
CTLA-4; polymorphisms; rheumatoid arthritis;
D O I
10.1080/030097402760375142
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study is to investigate the significance of the polymorphisms of the cytotoxic T lymphocyte associated antigen-4 (CTLA-4) exon 1(+ 49) and promoter(-318) genes in rheumatoid arthritis (RA). Polymerase chain reaction of genomic DNA-restriction fragment length polymorphism was used to determine genotypes of the CTLA-4 exon 1(+ 49) and promoter(-318) in 86 RA patients and 86 healthy control subjects. There was no significant difference in genotype, allele and phenotype frequencies of the CTLA-4 exon 1(+ 49) and promoter(-318) genes between RA patients and control subjects. There was no significant difference in age at onset, severity, functional class (greater than or equal to 3), physician global assessment, ESR, CRP or RF titer in patients with RA according to the CTLA-4 polymorphisms. Our data show that the polymorphisms within the CTLA-4 exon 1(+ 49) and promoter(-318) genes are not associated with susceptibility to RA and its clinical/serological manifestations in the Korean population.
引用
收藏
页码:266 / 270
页数:5
相关论文
共 26 条
[1]  
ALBANI S, 1992, RHEUM DIS CLIN N AM, V18, P729
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]   A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis [J].
Barton, A ;
Myerscough, A ;
John, S ;
Gonzalez-Gay, M ;
Ollier, W ;
Worthington, J .
RHEUMATOLOGY, 2000, 39 (01) :63-66
[4]  
Daikh DI, 1997, J IMMUNOL, V159, P3104
[5]   HUMAN IG SUPERFAMILY CTLA-4 GENE - CHROMOSOMAL LOCALIZATION AND IDENTITY OF PROTEIN-SEQUENCE BETWEEN MURINE AND HUMAN CTLA-4 CYTOPLASMIC DOMAINS [J].
DARIAVACH, P ;
MATTEI, MG ;
GOLSTEIN, P ;
LEFRANC, MP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (12) :1901-1905
[6]   An Mse I RFLP in the human CTLA4 promotor [J].
Deichmann, K ;
Heinzmann, A ;
Bruggenolte, E ;
Forster, J ;
Kuehr, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) :817-818
[7]   TREATMENT OF MURINE LUPUS WITH CTLA4IG [J].
FINCK, BK ;
LINSLEY, PS ;
WOFSY, D .
SCIENCE, 1994, 265 (5176) :1225-1227
[8]   CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis [J].
Gonzalez-Escribano, MF ;
Rodriguez, R ;
Valenzuela, A ;
Garcia, A ;
Garcia-Lozano, JR ;
Nuñez-Roldan, A .
TISSUE ANTIGENS, 1999, 53 (03) :296-300
[9]   POTENTIAL ROLES OF THE B7 AND CD28 RECEPTOR FAMILIES IN AUTOIMMUNITY AND IMMUNE EVASION [J].
HARLAN, DM ;
ABE, R ;
LEE, KP ;
JUNE, CH .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 75 (02) :99-111